The present application relates generally to the imaging arts and more particularly to the generation of attenuation maps for use in electronic image reconstruction. It has application at least in single-photon emission computed tomography (SPECT) imaging without the need for an additional transmission measurement from another imaging modality, such as computed tomography (CT) or magnetic resonance (MR), or an additional transmission source, such as a line- or point-source attached to the SPECT scanner, and will be described with particular reference thereto. However, it also finds more general application in generating attenuation maps for use with other radioemission-based imaging, including, but not limited to positron emission tomography (PET), and in other arts.
Radioemission-based imaging devices, such as SPECT or PET imaging devices, include detectors that detect electromagnetic radiation emitted from radioactive isotopes, such as a radiopharmaceutical administered to a patient. The detectors typically include a sheet of scintillation crystal material that interacts with gamma rays emitted by the isotope to produce photons in the visible light spectrum known as “events.”
In a conventional SPECT study, such as the study of a patient's organ, the radioisotope administered to the patient is adapted to be taken up by the particular organ or region of the body to be studied. Then, the patient is placed on an imaging bed of a SPECT system. A gamma or scintillation camera including one or more detectors is rotated about the long axis of the patient detecting gamma emissions from the patient's body at various angular orientations about the axis. The resulting data is used to form a set of multiple two-dimensional images (also called projections, projection images or sinograms). Three-dimensional SPECT images (known as SPECT images or tomographic images) of the distribution of the radioisotope within the patient can be calculated based on this set of two-dimensional images. This calculation process is known as image reconstruction.
However, a significant portion of the photons emitted from the radioisotope interact with tissue or other material between the radiation source and the detector. That interaction typically prevents some photons from reaching the detector (attenuation) and changes the direction of some photons (scatter). The degree of attenuation and scatter will vary from patient to patient and depends upon the physical characteristics of the matter (i.e., bone, muscle, organ tissue, etc.) between the emitting source and the detector. As a consequence of attenuation and scatter, quantitative data obtained from SPECT imaging devices must be appropriately processed to accurately represent the distribution of the radioisotope within a patient's body.
The attenuation and scatter of emitted radiation as it passes through the imaged subject may be accounted for during image reconstruction in a process known as attenuation correction. Attenuation correction is now an integral part of nuclear medicine image reconstruction. Toward this end, an attenuation map (μ map) of the imaged subject is advantageously provided to be used in attenuation correction during the reconstruction process (as done with the Philips Astonish software program). Many prior art techniques for attenuation correction in SPECT have assumed that the attenuation coefficient of the body is uniform. However, this is an oversimplification, as the human body is not homogenous in terms of radiation attenuation and the attenuation coefficient may vary greatly for different areas of the body due to varying mass, density, and other characteristics. Accordingly, assuming a uniform attenuation coefficient throughout the entire body often introduces errors into the image reconstruction.
A more accurate attenuation map of the imaging subject can be generated using another imaging modality, such as CT or MR imaging data acquired from the imaged subject. Such imaging data may be acquired using a radiation source arranged to transmit radiation through the subject, such as x-rays generated by an x-ray tube or radiation generated by a Gd-153 line source. The CT image produced by transmission CT projection data is indicative of the absorption of radiation transmitted through the imaging subject. Such radiation absorption is qualitatively similar to the absorption of gamma rays emitted by radiopharmaceuticals. For example, both x-rays and gamma rays are absorbed more by bone as compared with softer tissue. As a result, CT imaging data can be used to estimate an attenuation map for gamma rays emitted by the radiopharmaceutical. Similar transmission data can also be obtained by the use of dedicated external SPECT scanner hardware extensions, such as Gd line- or point-sources attached to the SPECT scanner.
The use of such additional external radiation sources (such as x-rays or gamma rays) to generate an attenuation map has several weaknesses. These methods, especially the use of CT, result in a higher radiation exposure to the patient, which can be a significant drawback due to safety concerns. Another shortcoming of the use of an additional imaging modality, such as CT, is the difficulty in registering the CT data and the SPECT data if both scans are performed in succession rather than simultaneously on a mixed modality scanner (e.g. SPECT/CT scanner). Any misalignment of the two images provides erroneous radiation attenuation information which impairs the diagnostic value of the reconstructed images. Furthermore, if both the SPECT and CT scans are performed simultaneously (“in parallel”), the need for an external transmission isotope can limit the variety of radiopharmaceuticals that can be effectively administered to the patient. Moreover, use of an external transmission source adds additional hardware with associated maintenance requirements. Finally, if a CT imaging device with diagnostic image quality is used, the data may have to be adjudged by a physician (depending upon the relevant governing law) adding time and expense to the image reconstruction process.
It is generally known that the SPECT emission data contains information from which an attenuation map could theoretically be derived without the need of an additional transmission source. Several techniques have been developed for deriving attenuation maps from emission data. Examples include: Y. Censor, D. E. Gustafson, A. Lent, and H. Tuy, “A New Approach to the Emission Computerized Topography Problem: Simultaneous Calculation of Attenuation and Activity Coefficients,” IEEE Trans. Nucl. Sci., Vol. 26, pp. 2775-2779 (1979); J. Nuyts, P. Dupont, S. Stroobants, R. Benninck, L. Mortelmans, and P. Suetens, “Simultaneous Maximum a Posteriori Reconstruction of Attenuation and Activity Distribution from Emission Sinograms,” IEEE Transactions On Medical Imaging, Vol. 140, pp. 393-403 (1999); F. Natterer, “Determination of Tissue Attenuation in Emission Tomography of Optically Dense Media,” Inverse Problems, Vol. 9, pp. 731-736 (1993); and A. V. Bronnikov, “Reconstruction of Attenuation Maps Using Discrete Consistency Conditions,” IEEE Transactions On Medical Imaging, Vol. 19, No. 5, pp. 451-462 (2000). Another method of utilizing SPECT emission data to generate an attenuation map is disclosed in U.S. Pat. No. 6,310,968 entitled “Source-Assisted Attenuation Correction for Emission Computed Tomography,” the entire disclosure of which is hereby incorporated by reference. Additional iterative techniques, such as maximum likelihood expectation maximization (ML-EM) reconstruction and iterative weighted least squares/conjugate gradient (WLS/CG) reconstruction, and various other methods have also been used. Each of the aforementioned techniques are calculation-intensive and require a large amount of time and computing power to complete. Their commercial use has therefore largely been limited to two-dimensional image reconstruction. Therefore, it would be advantageous to provide a faster iterative reconstruction method requiring less time and computing power, which may find commercial use in three-dimensional image reconstruction.
According to one aspect of the present invention, a method is provided for generating an attenuation map with the use of emission data and without the need for an additional transmission measurement.
According to another aspect of the present invention, an imaging reconstruction method is provided. An attenuation map is generated with the use of emission data and without the need for an additional transmission measurement. Acquired SPECT or PET emission data are reconstructed into a SPECT or PET image using the attenuation map and an iterative reconstruction method which reconstructs the emission map and attenuation map simultaneously, based on the same data.
According to another aspect of the present invention, an imaging system and apparatus is provided for practicing the method.
One advantage resides in generating more accurate attenuation maps. Another advantage resides in more accurate SPECT, PET, or other radioemission-based imaging data reconstruction. Another advantage resides in reduced image artifacts. Yet another advantage resides in reduced patient exposure to radiation because an additional transmission scan is not necessary. Numerous additional advantages and benefits will become apparent to those of ordinary skill in the art upon reading the following detailed description of the preferred embodiments.
The invention may take form in various components and arrangements of components, and in various process operations and arrangements of process operations.
The drawings are only for the purpose of illustrating preferred embodiments and are not to be construed as limiting the invention.
The medical diagnostic imaging system and apparatus of the present application is generally any nuclear medicine scanner that detects and records the spatial, temporal, and/or other characteristics of emitted photons, for example, a SPECT scanner or PET scanner. More specifically, with reference to
Each of the detector heads 150 has a radiation-receiving face adapted to face the subject-receiving aperture 140 that includes a scintillation crystal, such as a large doped sodium iodide crystal, that emits a flash of light or photons in response to incident radiation. An array of photomultiplier tubes or other suitable photodetectors receives the light and converts it into electrical signals. A resolver circuit 170 resolves the x, y-coordinates of each flash of light and the energy of the incident radiation. In other words, radiation strikes the scintillation crystal causing the scintillation crystal to scintillate, i.e., emit light photons in response to the radiation. The photons are directed toward the photomultiplier tubes. Relative outputs of the photomultiplier tubes are processed and corrected to generate an output signal indicative of (i) a position coordinate on the detector head at which each radiation event is received, and (ii) an energy or “activity” of each event. The energy or activity is used to differentiate between various types of radiation such as multiple emission radiation sources, stray and secondary emission radiation, and to eliminate noise.
Optionally, the detector heads 150 include mechanical collimators 160 mounted on the radiation receiving faces of the detector heads 150. The collimators 160 preferably include an array or grid of radiation-absorbent vanes which restrict the detector heads 150 from receiving radiation not traveling along selected rays in accordance with the data type being collected (i.e., parallel beam, fan beam, and/or cone beam). In certain embodiments, the collimators 160 restrict the detector heads 150 from receiving any radiation not traveling along rays normal to the radiation receiving faces of the detector heads 150. Alternately, other collimation geometries can be employed.
In a conventional SPECT imaging study, one or more radiopharmaceutical or radioisotopes is administered to the imaged subject such that emission radiation is emitted therefrom, as discussed above. In operation, the detector heads 150 are rotated or indexed around the subject to monitor radiation from a plurality of directions. For example, the rotating gantry 130 and detector heads 150 may rotate around the imaging subject a full 360° revolution during a given study taking scans at multiple discrete locations within the 360° revolution. It should also be understood that the gantry 130 and detector heads 150 may rotate over a smaller arc or make multiple revolutions around the imaging subject as well.
Multiple two dimensional images (also called projections) are acquired at defined points during the rotation of the rotating gantry 130, typically every 3-6 degrees. The emission projection data (or measured sinogram) received by the detector heads is sorted by a resolver circuit 170 or other device, and stored in an emission memory 180 of an imaging processor 181. A SPECT reconstruction data processor 182 of the imaging processor 181 is then used to apply a reconstruction algorithm to the multiple projections to generate a SPECT image made up of image elements such as pixels (for a two-dimensional image slice or parallel array of two-dimensional image slices) or voxels (for a three-dimensional image). Such reconstruction algorithms may include, for example, filtered backprojection, an iterative reconstruction algorithm, a Fourier transform-based reconstruction algorithm, or another reconstruction algorithm. However, as previously discussed, the emission projection data generally contains inaccuracies caused by attenuation and scatter. For this reason, the following attenuation correction procedure is proposed.
Referring now to
Organ shape models 230 obtained from organ shape databases or other catalogued sources of a priori organ knowledge (e.g., location, orientation, size and shape of organs and so forth) are used to further refine the estimated organ boundaries. Examples of such databases include prior knowledge regarding internal body structures such as the lungs, bones, intestine, heart and liver. One example of such a database is the NCAT-phantom (http://www.bme.unc.edu/˜wsegars/). Some of these databases account for organ motion over time and the gender of the patient. It should be understood that the organ shape models 230 may be obtained from an external database or may be stored internally within the imaging processor 181 of the SPECT imaging system 100 in an optional reference memory 184. The estimated outer body contour and organ boundaries 220 and the organ shape models 230 are collectively analyzed to generate an estimate of the entire body regions 240 of the imaged subject in the form of a three-dimensional contour map or mesh made up of a plurality of voxels. This may involve, for example, an analysis of the spatial relationships between organs and the estimated outer body contour, the estimated location, size, orientation and shape of organs from the OSEM reconstructed image, and the a priori organ knowledge 230. In this way, each voxel of the 3D mesh is assigned to one type of several potential body regions, such as heart, liver, bone, skeletal muscle, or other issue type. If a particular patient has already been imaged, that prior data can be used to improve this estimation.
Once initially determined, the location, size and shape of these voxels in the 3D mesh are typically not thereafter varied. In other words, in some embodiments, only topology preserving adaptation of the voxels of the 3D mesh are carried out so the number of voxels remains constant (i.e., no merging or overlapping of voxels, no splitting of voxels, etc.). However, there are also “unconstrained grid” approaches based on a dynamic adaption of the local voxel structure and mesh node density during the reconstruction process. The proposed method can be adapted in alternative embodiments to support such “unconstrained grid” approaches. Each time the grid is modified according to the intermediate reconstruction result for the activity distribution, this adaption could also be applied on the structure representing the attenuation coefficient distribution. Subsequently, both unconstrained grids would match and the reconstruction method is continued as described herein.
Based on a priori knowledge, each type of body region may be assigned one attenuation coefficient to generate a collection of attenuation coefficients 250. The attenuation coefficient assigned to a particular body region represents an average attenuation which may be expected from that body particular region. For example, the “skeletal muscle” attenuation coefficient will likely be less than the “bone” attenuation coefficient, because skeletal muscles are typically less dense than bones leading to less attenuation of emission radiation. To help simplify the computations and thus reduce the time to generate useful images, each body region may be assigned one single attenuation coefficient. In that case, once a particular voxel in the 3D mesh is assigned to a particular body region, the attenuation coefficient for that voxel is automatically determined. For example, each of the voxels in the body region estimate 240 estimated to correspond to bones is assigned the same “bone” attenuation coefficient, each of the voxels in the body region estimate 240 estimated to correspond to a lung is assigned the same “lung” attenuation coefficient, and so on. Every distinct body region is thereby homogenously assigned one attenuation value.
However, in alternative embodiments, each body region may be assigned an attenuation coefficient that is selected from a range of attenuation coefficients that correspond to that body region. For example, each of the voxels in the body region estimate 240 that are estimated to correspond to bones may be assigned an attenuation coefficient selected from a range of predetermined “bone” attenuation coefficients based upon certain characteristics of the particular voxel, such as the location of the voxel relative to the outer body contour, the location of the voxel relative to the estimated bone boundaries, etc. In this instance, once a particular voxel in the 3D mesh is assigned to a particular body region, an additional selection process is carried out to select an attenuation Coefficient for that voxel from a range of attenuation coefficients for that particular body region.
Once each of the voxels of the body region estimate 240 is assigned an attenuation coefficient, this information is compiled to create a three-dimensional attenuation map estimate or n map 260 (or “B”). In one embodiment, this attenuation map estimate 260 is stored internally in the imaging processor 181 of the SPECT imaging device 100 in an attenuation memory 186. Generally, the number of voxels in the attenuation map estimate 260 is determined based upon the number of voxels (or granularity) of the particular emission map being used in the reconstruction. The attenuation map estimate 260 may have an identical number of voxels as the emission map in some embodiments (e.g., the attenuation map may be a 128 voxel by 128 voxel map and the emission map may be a 128 voxel by 128 voxel map). Alternatively, the attenuation map estimate 260 may have a different number of voxels than the emission map. In that case, the attenuation map estimate 260 typically has less granularity than the emission map by a factor of two (e.g., if the emission map is a 128 voxel by 128 voxel map, a 64 voxel by 64 voxel attenuation map estimate is generated) to allow for efficient registration of the attenuation map estimate 260 with the emission map.
The attenuation coefficients 250 discussed above may be obtained from various sources. As already discussed, in one embodiment the attenuation coefficients 250 may be in the form of a database including one attenuation coefficient for each body region designation (i.e., heart, lung, other organ, muscle, bone, or other tissue type) or a database including a range of attenuation coefficients for each body region designation. In additional embodiments, the attenuation coefficients 250 may be customized to allow them to be more accurately tailored to the particular imaged subject. To provide for this customization, the attenuation coefficients 250 may be chosen based upon various characteristics of the imaged subject (i.e., age, size, weight, gender, etc.). Appropriate attenuation coefficients 250 for a given imaged subject may then be selected from this collection based upon the characteristics of the imaged subject. Preferably, however, for a particular imaged subject only a single attenuation coefficient or range of coefficients is chosen for each body region. As with the organ shape models 230, the attenuation coefficients 250 may be obtained from an external database or may be stored internally within the SPECT imaging system 100 in an optional reference memory 184.
Referring now to
Referring now to
and
In alternate embodiments, the following algorithm may be used to account for multiple/isotope nuclide measurements and scatter:
and
The attenuation map corrections 420 are then utilized to generate an updated attenuation map estimate 430 corresponding to an updated body region as described above. In this way, a given voxel initially estimated to be a “heart” voxel (with an associated attenuation coefficient) may become a “lung” voxel (with a different associated attenuation coefficient), and so forth.
Referring now to
Referring again to
To simplify the iterative process, and reduce the computing time, the attenuation map processing may be limited to the boundary area between estimated body regions. This reduces the regions of interest to multiple series of linked or chained voxels defining the outer contours of these regions, reducing the issue from a two-dimensional calculation to a one-dimensional calculation.
The simultaneous iterative reconstruction of the estimated emission map and estimated attenuation map is continued until a threshold level of convergence between the measured emission projection data “A” and the estimated emission map “D” is satisfied. This may be calculated as either an acceptably low error between “A” and “D,” or a minimum consistency between “A” and “D.” This threshold level of convergence may vary from image study to image study.
Upon completion of the final iteration, the final back-projected emission map “D” is then formatted by the image processor 192 into an image representation of the imaged subject for viewing on a display device 194, such as a video monitor or other suitable device. Also, the final estimated attenuation map “B” may be viewed and modified by a clinician as an additional quality control step.
The invention has been described with reference to the preferred embodiments. Obviously, modifications and alterations will occur to others upon reading and understanding the preceding detailed description. It is intended that the invention be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof. The invention may take form in various components and arrangements of components, and in various steps and arrangements of steps. The drawings are only for purposes of illustrating the preferred embodiments and are not to be construed as limiting the invention.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB08/54501 | 10/29/2008 | WO | 00 | 7/23/2010 |
Number | Date | Country | |
---|---|---|---|
60986691 | Nov 2007 | US | |
61042794 | Apr 2008 | US |